Holen Sie sich die Stockscreener-App
1.78
3.26%
-0.06
Handel nachbörslich:
1.78
Schlusskurs vom Vortag:
$1.84
Offen:
$1.84
24-Stunden-Volumen:
210.50K
Relative Volume:
0.60
Marktkapitalisierung:
$93.40M
Einnahmen:
$21.05M
Nettoeinkommen (Verlust:
$-89.22M
KGV:
-0.9944
EPS:
-1.79
Netto-Cashflow:
$-64.50M
1W Leistung:
+3.49%
1M Leistung:
-6.32%
6M Leistung:
+23.18%
1J Leistung:
-64.54%
1-Tages-Spanne:
$1.75
$1.855
1-Wochen-Bereich:
$1.68
$1.87
52-Wochen-Spanne:
$1.02
$6.225
Tscan Therapeutics Inc Stock (TCRX) Company Profile
Firmenname
Tscan Therapeutics Inc
Sektor
Branche
Telefon
857-399-9500
Adresse
830 WINTER STREET, WALTHAM
Vergleichen Sie TCRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TCRX
Tscan Therapeutics Inc
|
1.78 | 104.42M | 21.05M | -89.22M | -64.50M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-16 | Eingeleitet | BTIG Research | Buy |
| 2024-05-13 | Eingeleitet | Needham | Buy |
| 2023-06-22 | Eingeleitet | Wedbush | Outperform |
Tscan Therapeutics Inc Aktie (TCRX) Neueste Nachrichten
Short interest data insights for TScan Therapeutics Inc.July 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
H.C. Wainwright Maintains TScan Therapeutics(TCRX.US) With Buy Rating, Maintains Target Price $10 - 富途牛牛
Risk adjusted return profile for TScan Therapeutics Inc. analyzedTrade Performance Summary & Growth Focused Entry Point Reports - newser.com
TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Consensus Rating of “Buy” from Analysts - Defense World
Brokerages Set TScan Therapeutics, Inc. (NASDAQ:TCRX) PT at $7.80 - MarketBeat
How to build a custom watchlist for TScan Therapeutics Inc.July 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
What the charts say about TScan Therapeutics Inc. todayQuarterly Performance Summary & Target Return Focused Stock Picks - newser.com
Energy Moves: Will TScan Therapeutics Inc benefit from seasonalityDip Buying & Fast Entry Momentum Trade Alerts - خودرو بانک
TScan Therapeutics Inc. stock daily chart insightsChart Signals & High Accuracy Swing Trade Signals - newser.com
Short Squeeze: Can TKNO maintain sales growth2025 Investor Takeaways & Fast Gain Swing Alerts - khodrobank.com
Is TScan Therapeutics Inc. meeting your algorithmic filter criteria2025 Valuation Update & Safe Capital Growth Tips - newser.com
Can machine learning forecast TScan Therapeutics Inc. recoveryQuarterly Portfolio Report & Low Risk Investment Opportunities - newser.com
Is TScan Therapeutics Inc stock a good dividend stockTrade Entry Report & Capital Efficiency Focused Strategies - خودرو بانک
TScan Therapeutics Inc. stock chart pattern explainedPortfolio Update Report & Verified Technical Trade Signals - newser.com
How to recover losses in TScan Therapeutics Inc. stock2025 Market Outlook & Long-Term Safe Return Strategies - newser.com
Will TScan Therapeutics Inc. stock recover after recent dropEarnings Summary Report & Growth Oriented Trade Recommendations - newser.com
Aug Levels: Can TScan Therapeutics Inc. benefit from deglobalization2025 Bull vs Bear & AI Forecast for Swing Trade Picks - خودرو بانک
Aug Reactions: Will TScan Therapeutics Inc stock benefit from M A2025 Market Overview & High Accuracy Swing Trade Signals - خودرو بانک
TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025 - The Manila Times
TScan Therapeutics Announces Acceptance of Two Abstracts at ACR Convergence 2025 on T Cell Targets in Autoimmune Disorders - Quiver Quantitative
TScan Therapeutics Announces Upcoming Oral and Poster - GlobeNewswire
First-Ever T Cell Targets Found in Ankylosing Spondylitis: TScan's TargetScan Platform Makes Breakthrough Discovery - Stock Titan
Using Ichimoku Cloud for TScan Therapeutics Inc. technicalsJuly 2025 Selloffs & Short-Term High Return Ideas - newser.com
will tscan therapeutics inc. stock recover after recent drop2025 Price Targets & Scalable Portfolio Growth Ideas - newser.com
How to forecast TScan Therapeutics Inc. trends using time seriesJuly 2025 Decliners & Weekly High Potential Stock Alerts - newser.com
Fed Meeting: Is TScan Therapeutics Inc stock risky to hold nowWeekly Trade Analysis & Real-Time Price Movement Reports - خودرو بانک
Tech Rally: What are TScan Therapeutics Incs technical support levelsJuly 2025 Outlook & Weekly High Return Opportunities - خودرو بانک
How institutional ownership impacts TScan Therapeutics Inc. stockWeekly Profit Recap & Stepwise Trade Signal Guides - newser.com
Stop Loss: Will TScan Therapeutics Inc. stock hit new highs in YEARJuly 2025 Macro Moves & Breakout Confirmation Alerts - خودرو بانک
Wall Street Recap: Can TScan Therapeutics Inc. continue delivering strong returnsEarnings Growth Summary & Risk Managed Investment Strategies - خودرو بانک
Block Trades: Does Envirotech Vehicles Inc have high return on assetsEarnings Growth Summary & Real-Time Volume Triggers - خودرو بانک
Inflation Data: Whats next for TScan Therapeutics Inc stockEarnings Growth Summary & Long-Term Capital Growth Strategies - خودرو بانک
Patterns Watch: Is TScan Therapeutics Inc stock a good dividend stockQuarterly Profit Review & AI Powered Buy/Sell Recommendations - خودرو بانک
Published on: 2025-09-16 04:40:28 - خودرو بانک
Analyzing net buyer seller activity in TScan Therapeutics Inc.July 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
Analyst Downgrade: What is the next catalyst for TScan Therapeutics IncStop Loss & Weekly Watchlist for Hot Stocks - خودرو بانک
US Market Wrap: Whats next for TScan Therapeutics Inc stockJuly 2025 Rallies & Daily Momentum Trading Reports - خودرو بانک
Fed Meeting: Can Ekso Bionics Holdings Inc grow without dilutionJuly 2025 Spike Watch & Daily Stock Trend Reports - خودرو بانک
Block Trades: Whats next for TScan Therapeutics Inc stockCEO Change & Scalable Portfolio Growth Methods - khodrobank.com
Buyback Watch: Is TScan Therapeutics Inc exposed to currency risksWatch List & High Conviction Investment Ideas - خودرو بانک
Finanzdaten der Tscan Therapeutics Inc-Aktie (TCRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):